DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

DCM Shriram Limited — Press Release

NSE 1 hr ago·26 Oct 2026, 1:16 pm

DCM Shriram

DCM Shriram Limited has informed the Exchange regarding a press release dated October 26, 2026, titled "Press release regarding Unaudited Financial Results (both Standalone and Consolidated) for the quarter and half year ended 30th September 2026".

Affected stocks

Neutral1 stock

DCM Shriram

DCMSHRIRAM Neutral

₹968.35

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns DCM Shriram (DCMSHRIRAM).
Category: Results.

Why it matters

A routine update for DCM Shriram. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Company SEBI

SEBI Order for Compliance - General Remittance Order dated 26.10.2026 in Recovery Certificate No. 8511 of 2025 issued against Add Life Pharma Ltd in the matter of Add Life Pharma Ltd.

SEBI · 20 min ago

Company SEBI

SEBI Order for Compliance - Release Order for Recovery Certificate No. 8484 of 2024 against NARENDRABHAI AMIN (PAN- AMGPA3864Q) in the matter of M/s Austral Coke and Projects Limited - II

SEBI · 20 min ago